Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1996 Sep 14;313(7058):665–669. doi: 10.1136/bmj.313.7058.665

Routine follow up of breast cancer in primary care: randomised trial.

E Grunfeld 1, D Mant 1, P Yudkin 1, R Adewuyi-Dalton 1, D Cole 1, J Stewart 1, R Fitzpatrick 1, M Vessey 1
PMCID: PMC2351993  PMID: 8811760

Abstract

OBJECTIVE: To assess the effect on time to diagnosis of recurrence and on quality of life of transferring primary responsibility for follow up of women with breast cancer in remission from hospital to general practice. DESIGN: Randomised controlled trial with 18 month follow up in which women received routine follow up either in hospital or in general practice. SUBJECTS AND SETTING: 296 women with breast cancer in remission receiving regular follow up care at district general hospitals in England. MAIN OUTCOME MEASURES: Time between first presentation of symptoms to confirmation of recurrence; quality of life measured by specific dimensions of the SF-36 schedule, the EORTC symptom scale, and hospital anxiety and depression scale. RESULTS: Most recurrences (18/26, 69%) presented as interval events, and almost half (7/16, 44%) of the recurrences in the hospital group presented first to general practice. The median time to hospital confirmation of recurrence was 21 days in the hospital group (range 1-376 days) and 22 days in the general practice group (range 4-64). The differences between groups in the change in SF-36 mean scores from baseline were small: -1.8 (95% confidence interval -7.2 to 3.5) for social functioning, 0.5 (-4.1 to 5.1) for mental health, and 0.6 (-3.6 to 4.8) for general health perception. The change from baseline in the mean depression score was higher in the general practice group at the mid-trial assessment (difference 0.6, 0.1 to 1.2) but there was no significant difference between groups in the anxiety score or the EORTC scales. CONCLUSION: General practice follow up of women with breast cancer in remission is not associated with increase in time to diagnosis, increase in anxiety, or deterioration in health related quality of life. Most recurrences are detected by women as interval events and present to the general practitioner, irrespective of continuing hospital follow up.

Full text

PDF
665

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaronson N. K., Ahmedzai S., Bergman B., Bullinger M., Cull A., Duez N. J., Filiberti A., Flechtner H., Fleishman S. B., de Haes J. C. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993 Mar 3;85(5):365–376. doi: 10.1093/jnci/85.5.365. [DOI] [PubMed] [Google Scholar]
  2. Brøyn T., Frøyen J. Evaluation of routine follow-up after surgery for breast carcinoma. Acta Chir Scand. 1982;148(5):401–404. [PubMed] [Google Scholar]
  3. Dewar J. A., Kerr G. R. Value of routine follow up of women treated for early carcinoma of the breast. Br Med J (Clin Res Ed) 1985 Nov 23;291(6507):1464–1467. doi: 10.1136/bmj.291.6507.1464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Grunfeld E., Mant D., Vessey M. P., Fitzpatrick R. Specialist and general practice views on routine follow-up of breast cancer patients in general practice. Fam Pract. 1995 Mar;12(1):60–65. doi: 10.1093/fampra/12.1.60. [DOI] [PubMed] [Google Scholar]
  5. Hollen P. J., Hobbie W. L. Establishing comprehensive specialty follow-up clinics for long-term survivors of cancer. Providing systematic physiological and psychosocial support. Support Care Cancer. 1995 Jan;3(1):40–44. doi: 10.1007/BF00343920. [DOI] [PubMed] [Google Scholar]
  6. James N. D., Guerrero D., Brada M. Who should follow up cancer patients? Nurse specialist based outpatient care and the introduction of a phone clinic system. Clin Oncol (R Coll Radiol) 1994;6(5):283–287. doi: 10.1016/s0936-6555(05)80267-5. [DOI] [PubMed] [Google Scholar]
  7. Loomer L., Brockschmidt J. K., Muss H. B., Saylor G. Postoperative follow-up of patients with early breast cancer. Patterns of care among clinical oncologists and a review of the literature. Cancer. 1991 Jan 1;67(1):55–60. doi: 10.1002/1097-0142(19910101)67:1<55::aid-cncr2820670111>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  8. Loprinzi C. L. It is now the age to define the appropriate follow-up of primary breast cancer patients. J Clin Oncol. 1994 May;12(5):881–883. doi: 10.1200/JCO.1994.12.5.881. [DOI] [PubMed] [Google Scholar]
  9. Pandya K. J., McFadden E. T., Kalish L. A., Tormey D. C., Taylor S. G., 4th, Falkson G. A retrospective study of earliest indicators of recurrence in patients on Eastern Cooperative Oncology Group adjuvant chemotherapy trials for breast cancer. A preliminary report. Cancer. 1985 Jan 1;55(1):202–205. doi: 10.1002/1097-0142(19850101)55:1<202::aid-cncr2820550132>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  10. Richert-Boe K. E. Heterogeneity of cancer surveillance practices among medical oncologists in Washington and Oregon. Cancer. 1995 May 15;75(10):2605–2612. doi: 10.1002/1097-0142(19950515)75:10<2605::aid-cncr2820751031>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  11. Rosselli Del Turco M., Palli D., Cariddi A., Ciatto S., Pacini P., Distante V. Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up. JAMA. 1994 May 25;271(20):1593–1597. doi: 10.1001/jama.271.20.1593. [DOI] [PubMed] [Google Scholar]
  12. Scanlon E. F., Oviedo M. A., Cunningham M. P., Caprini J. A., Khandekar J. D., Cohen E., Robinson B., Stein E. Preoperative and follow-up procedures on patients with breast cancer. Cancer. 1980 Aug 15;46(4 Suppl):977–979. doi: 10.1002/1097-0142(19800815)46:4+<977::aid-cncr2820461320>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  13. Schapira D. V., Urban N. A minimalist policy for breast cancer surveillance. JAMA. 1991 Jan 16;265(3):380–382. [PubMed] [Google Scholar]
  14. Tomiak E., Piccart M. Routine follow-up of patients after primary therapy for early breast cancer: changing concepts and challenges for the future. Ann Oncol. 1993 Mar;4(3):199–204. doi: 10.1093/oxfordjournals.annonc.a058456. [DOI] [PubMed] [Google Scholar]
  15. Wertheimer M. D. Against minimalism in breast cancer follow-up. JAMA. 1991 Jan 16;265(3):396–397. [PubMed] [Google Scholar]
  16. Winchester D. P., Sener S. F., Khandekar J. D., Oviedo M. A., Cunningham M. P., Caprini J. A., Burkett F. E., Scanlon E. F. Symptomatology as an indicator of recurrent or metastatic breast cancer. Cancer. 1979 Mar;43(3):956–960. doi: 10.1002/1097-0142(197903)43:3<956::aid-cncr2820430326>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  17. Worster A., Bass M. J., Wood M. L. Willingness to follow breast cancer. Survey of family physicians. Can Fam Physician. 1996 Feb;42:263–268. [PMC free article] [PubMed] [Google Scholar]
  18. Zigmond A. S., Snaith R. P. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x. [DOI] [PubMed] [Google Scholar]
  19. Zwaveling A., Albers G. H., Felthuis W., Hermans J. An evaluation of routine follow-up for detection of breast cancer recurrences. J Surg Oncol. 1987 Mar;34(3):194–197. doi: 10.1002/jso.2930340314. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES